FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)

View source ↗

Summary

The FDA approved a supplemental application for Walgreens' NICOTINE POLACRILEX MINT, a nicotine polacrilex product intended to aid smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• NICOTINE POLACRILEX MINT (nicotine polacrilex)

Snippet

SUPPL AP for NICOTINE POLACRILEX MINT (NICOTINE POLACRILEX)